Page last updated: 2024-11-07

dehydroepiandrosterone and Vascular Diseases

dehydroepiandrosterone has been researched along with Vascular Diseases in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research Excerpts

ExcerptRelevanceReference
"Type 2 diabetes mellitus is increasing globally and is an established risk factor for the development of atherosclerotic vascular disease."2.43Androgens, insulin resistance and vascular disease in men. ( Channer, KS; Jones, TH; Kapoor, D; Malkin, CJ, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dumas de la Roque, E1
Savineau, JP1
Bonnet, S1
Kapoor, D1
Malkin, CJ1
Channer, KS1
Jones, TH1

Reviews

2 reviews available for dehydroepiandrosterone and Vascular Diseases

ArticleYear
Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
    Pharmacology & therapeutics, 2010, Volume: 126, Issue:2

    Topics: Animals; Apoptosis; Cell Proliferation; Constriction, Pathologic; Dehydroepiandrosterone; Disease Mo

2010
Androgens, insulin resistance and vascular disease in men.
    Clinical endocrinology, 2005, Volume: 63, Issue:3

    Topics: Aged; Aging; Arteriosclerosis; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Humans; Insulin Re

2005